Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Stem cell therapy could help regenerate inner ear hair cells to treat hearing loss.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

c-Kit is important for heart regeneration and cancer development.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.